Keywords: sankyo, develop, searle, xemilofiban, japan, negotiated, rights

Sankyo To Develop Searle's Xemilofiban In Japan

Article | 07 August 1995

Print This

Sankyo has negotiated rights to codevelop and comarket Searle's novel antiplatelet agent xemilofiban in Japan. The drug is an orally-active ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in